64
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Network meta-analysis of treatment regimens for inoperable advanced hepatocellular carcinoma with portal vein invasion

, , &
Pages 1157-1168 | Published online: 04 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Astha Srivastava, Haresh Kunhi Parambath, Anjali V. Ramdulari, Harsh Saxena, Rishabh Kumar, Suyash Pandey, Shalimar, Subhash Gupta & Babban Jee. (2022) Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?. International Journal of Radiation Biology 98:10, pages 1495-1509.
Read now

Articles from other publishers (11)

Su Jong Yu, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Hyo-Cheol Kim, Jin Wook Chung, Jung-Hwan Yoon & Yoon Jun Kim. (2023) Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study. Journal of Liver Cancer 23:1, pages 166-176.
Crossref
. (2023) 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Journal of Liver Cancer 23:1, pages 1-120.
Crossref
梦剑 齐. (2023) Progress of TACE for Hepatocellular Carcinoma Combined with PVTT. Advances in Clinical Medicine 13:02, pages 1416-1420.
Crossref
Yasuteru Kondo, Tatsuki Morosawa, Soichiro Minami & Yasuhito Tanaka. (2022) DEB-TACE combined with hepatic artery infusion chemotherapy might be an affordable treatment option for advanced stage of HCC. Scientific Reports 12:1.
Crossref
. (2022) 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clinical and Molecular Hepatology 28:4, pages 583-705.
Crossref
. (2022) 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma. Korean Journal of Radiology 23:12, pages 1126.
Crossref
Fangzhou Luo, Mengxia Li, Jun Ding & Shusen Zheng. (2021) The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus. Frontiers in Oncology 11.
Crossref
Liang-Cheng Chen, Hon-Yi Lin, Shih-Kai Hung, Wen-Yen Chiou & Moon-Sing Lee. (2021) Role of modern radiotherapy in managing patients with hepatocellular carcinoma. World Journal of Gastroenterology 27:20, pages 2434-2457.
Crossref
Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Ana Rodríguez-Gutiérrez & Ángela Matías-Pérez. (2021) Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination. Cancers 13:2, pages 192.
Crossref
Nokjung Kim & Myung-Won You. (2019) Hepatocellular carcinoma and macrovascular tumor thrombosis: treatment outcomes and prognostic factors for survival. Japanese Journal of Radiology 37:11, pages 781-792.
Crossref
Hideki Iwamoto, Mika Nomiyama, Takashi Niizeki, Shigeo Shimose, Tomotake Shirono, Masahito Nakano, Manabu Satani, Syusuke Okamura, Yu Noda, Naoki Kamachi, Miwa Sakai, Hiroyuki Suzuki, Ryoko Kuromatsu, Etsuyo Ogo, Toshi Abe, Masatoshi Tanaka, Hironori Koga & Takuji Torimura. (2019) Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy. Oncology 96:4, pages 192-199.
Crossref